Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
24
NMPA:24
Drug Approvals
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20244590
- Approval Date
- Jul 30, 2024
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20244591
- Approval Date
- Jul 30, 2024
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20243703
- Approval Date
- May 15, 2024
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20243702
- Approval Date
- May 15, 2024
NMPA
Neomycin Sulfate Eye Drops
- Product Name
- 硫酸新霉素滴眼液
- Approval Number
- 国药准字H20184011
- Approval Date
- Nov 24, 2022
NMPA
Ciprofloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸环丙沙星滴眼液
- Approval Number
- 国药准字H20173170
- Approval Date
- Feb 25, 2022
NMPA
Chloramphenicol Eye Drops
- Product Name
- 氯霉素滴眼液
- Approval Number
- 国药准字H20173175
- Approval Date
- Feb 25, 2022
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found